Back to Search
Start Over
Randomized trial to assess the efficacy and safety of xyloglucan for the treatment of acute gastroenteritis in children
- Source :
- Food Science & Nutrition, Vol 11, Iss 12, Pp 7698-7706 (2023)
- Publication Year :
- 2023
- Publisher :
- Wiley, 2023.
-
Abstract
- Abstract Acute gastroenteritis is one of the most common diseases in children and an important cause of morbidity and mortality worldwide. No specific treatment is available; therefore, management is exclusively symptomatic. Xyloglucan has been approved in Europe as a class IIa medical device for restoration of the physiological functions of the intestinal wall. Our objective was to assess efficacy and safety of xyloglucan for the treatment of acute gastroenteritis in children. We performed a triple‐blind, randomized placebo‐controlled clinical trial in four primary care centers and one continued care hospital center. The study population comprised children with acute gastroenteritis aged >3 months and
Details
- Language :
- English
- ISSN :
- 20487177
- Volume :
- 11
- Issue :
- 12
- Database :
- Directory of Open Access Journals
- Journal :
- Food Science & Nutrition
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.4654d98a793c4734a0fb10d2fe0267c8
- Document Type :
- article
- Full Text :
- https://doi.org/10.1002/fsn3.3688